Inhaltsbereich
2020
- Recombinant viruses delivering the necroptosis mediator MLKL induce a potent antitumor immunity in mice. (pdf, 2,49 MB)
Van Hoecke L., Riederer S., Saelens X., Sutter G., Rojas J.J.
Oncolmmunology, 20 Aug 2020, 9:(1): e1802968, DOI: 10.1080/2162402X.2020.1802968
- Trick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise. (pdf, 1,45 MB)
Kubinski M., Beicht J., Gerlach T., Volz A., Sutter G., Rimmelzwaan G.F.
Vaccines (Basel). 2020;8(3):E451. Published 2020 Aug 12. doi:10.3390/vaccines8030451
- Combating COVID-19: MVA vector vaccines applied to the respiratory tract as promising approach towards protective immunity in the lung. (pdf, 294 K)
Förster R., Fleige H., Sutter G.
Frontiers in Immunology, 2020, Aug 07; 11:1959. doi:3389/fmmu.2020.01959
- Diverse variola virus (smallpox) strains were widespread in northern Europe in the Viking Age. (pdf, 727 KB)
Mühlemann B., Vinner L., Margaryan A., Wilhelmson H., Castro C. de la Fuente, Allentoft M.E., Damgaard P. de Barros, Hansen A.J., Nielsen S.H., Strand L.M., Bill J., Buzhilova A., Pushkina T., Falys C., Khartanovich V., Moiseyev V., Jorkov M.L. Schjellerup, Sorensen P.O., Magnusson Y., Gustin I., Schroeder H., Sutter G., Smith G.L., Drosten C., Fouchier R.A.M., Smith D.J., Willerslev E., Jones T.C., Sikora M.
Science, 2020, July 24;369(6502):eaaw8977. DOI: 10.1126/science.aaw8977
- Salety and immnogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. (pdf, 1,42 MB)
Koch T., Dahlke C., Fathi A., Kupke A., Krähling V., Okba N.M.A., Halwe S., Rohde C., Eickmann M., Volz A., Hesterkamp T., Jambrecina A., Borregaard S., Ly M.L., Zinser M.E., Bartels E., Poetsch J.S.H., Neumann R., Fux R., Schmiedel S., Lohse A.W., Haagmans B.L., Sutter G., Becker S., Addo M.M.
Lancet Infect Dis, 2020, Jul;20(7):827-838. doi:10.1016/S1473-3099(20)30248-6. Epub 2020 Apr 21
- A vital gene for modified vaccinia virus Ankara replication in human cells. (pdf, 621 KB)
Sutter G.
Proc Natl Acad Sci USA, 2020, Mar 24;117(12):6289-6291. doi/10.1073/pnas.2001335117, Epub.2020 Marz 16
- Selective reconstitution of IFN-y gene function in Ncr1+NK cells is sufficient to control systemic vacinia virus Infection. (pdf, 1,95 MB)
Borst K., Flindt S., Blank P., Larsen P.-K., Chhatbar C., Skerra J., Spanier J., Hirche C., König M., Alanentalo T., Hafner M., Waibler Z., Pfeffer K., Sexl V., Sutter G., Müller W., Graalmann T., Kalinke U.
PLoS Pathog, 2020, Feb 5;16(2):e1008279. doi:10.1371/jounal.ppat.1008279. eCollection 2020 Feb
- Obstetric Ultrasonography to Detect Fetal Abnormalities in a Mouse Model for Zika Virus Infektion. (pdf, 2,96 MB)
Forster D., Schwarz J.H., Brosinski K., Kalinke U., Sutter G., Volz A.
Viruses, 2020, Jan 7;12(1):72. doi:10.3390/v12010072
- A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice. (pdf, 2,57 MB)
Kalodimou G., Veit S., Jany S., Kalinke U., Broder C.C., Sutter G., Volz A.
Viruses, 2020, 12, 26. doi.10.3390/v12010026
Servicebereich